MAPT and tauopathy: To extend our human brain post-mortem findings to a mouse model with predictable pathological progression of tau, we used the well-studied PS19 strain of mice, which overexpress the P301S pathogenic mutant human tau in neurons and recapitulate hallmarks of tauopathy, including progressive tau pathology, cognitive dysfunction, and neurodegeneration [84, 96].